Lead Modification
510(k) K770135
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK770135 | Date7 Feb 1977 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
This device is classified as an Implantable Pacemaker Pulse-Generator Lead Modification, a component used to alter or adapt pacemaker leads for compatibility with implantable pulse generators. It facilitates adjustments to ensure proper electrical conduction and pacing functionality within cardiac rhythm management systems.
The Lead Modification is intended for use in clinical settings where pacemaker leads require modification to interface with pulse generators. Supplied as a reusable component, it is regulated under FDA 510(k) clearance (K770135) and falls under Device Classification DXY, associated with cardiovascular devices. No sterility or single-use specifications are indicated in the data.
Other devices from Elema-Schonander, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of this Lead Modification in cardiac rhythm management systems?
The Lead Modification is designed to adjust or adapt pacemaker leads so they can be properly connected to implantable pulse generators. This ensures reliable electrical conduction and pacing functionality within cardiac rhythm management systems, allowing for compatibility between leads and generators that may not otherwise interface correctly.
Is this device intended for single-use or can it be reused in multiple procedures?
This Lead Modification is explicitly described as a reusable component, meaning it is intended for use in multiple clinical procedures after proper cleaning and maintenance. It is not classified as a single-use device.
How is this device regulated, and what does that mean for its use in clinical settings?
The Lead Modification is regulated under the FDA’s 510(k) clearance pathway, specifically with clearance number K770135, and falls under Device Classification DXY for cardiovascular devices. This means it has been determined to be substantially equivalent to a legally marketed device and is approved for use in clinical settings where pacemaker lead modifications are required for compatibility with pulse generators.
What types of clinical settings or specialties would typically use this Lead Modification?
This device is intended for use in clinical settings where pacemaker leads need modification to interface with implantable pulse generators, such as electrophysiology labs, cardiac catheterization labs, or operating rooms during cardiac implant procedures. It is specifically associated with cardiovascular specialties, as indicated by its regulatory classification and advisory committee designation.